Acutus Medical Inc (AFIB) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Acutus Medical Inc (AFIB) has a cash flow conversion efficiency ratio of 0.350x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-4.06 Million) by net assets ($-11.59 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see AFIB market cap overview for the company's overall valuation and market capitalisation.
Acutus Medical Inc - Cash Flow Conversion Efficiency Trend (2018–2024)
This chart illustrates how Acutus Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Acutus Medical Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Acutus Medical Inc ranked by their cash flow conversion efficiency. Explore AFIB cash flow quality score to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
4BASEBIO UK SOCIETAS
LSE:4BB
|
-0.703x |
|
Jubilee Platinum
LSE:JLP
|
0.028x |
|
Vast Resources PLC
LSE:VAST
|
0.571x |
|
Logistics Development Group PLC
LSE:LDG
|
-0.005x |
|
Spectra Systems Corp
LSE:SPSY
|
0.210x |
|
GeoVax Labs Inc
NASDAQ:GOVX
|
-1.266x |
|
Braemar Plc
LSE:BMS
|
0.012x |
|
Urbanimmersive Inc
V:UI
|
-0.002x |
Annual Cash Flow Conversion Efficiency for Acutus Medical Inc (2018–2024)
The table below shows the annual cash flow conversion efficiency of Acutus Medical Inc from 2018 to 2024. View AFIB stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-11.59 Million | $-31.66 Million | 2.731x | -96.20% |
| 2023-12-31 | $-879.00K | $-63.12 Million | 71.807x | +6435.10% |
| 2022-12-31 | $75.02 Million | $-85.03 Million | -1.133x | -20.22% |
| 2021-12-31 | $105.73 Million | $-99.68 Million | -0.943x | -40.13% |
| 2020-12-31 | $126.58 Million | $-85.17 Million | -0.673x | -371.38% |
| 2019-12-31 | $-225.81 Million | $-55.99 Million | 0.248x | -3.25% |
| 2018-12-31 | $-131.82 Million | $-33.78 Million | 0.256x | -- |
About Acutus Medical Inc
Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well a… Read more